How do I buy Protagonist Therapeutics (PTGX) stock?

You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.View our list of the best stock brokerages

Who are Protagonist Therapeutics (PTGX) competitors?

Other companies in Protagonist Therapeutics’s space includes: Immunovant Inc (NASDAQ:IMVT), Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC), Alkermes PLC (NASDAQ:ALKS) and Vaxcyte Inc (NASDAQ:PCVX).

What is the forecast, or price target, for Protagonist Therapeutics (PTGX) stock?

Protagonist Therapeutics has a consensus price target of $78.47.

What is the current price for Protagonist Therapeutics (PTGX)?

The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $83.1 last updated January 23, 2026 at 5:14 PM EST.

Does Protagonist Therapeutics (PTGX) pay a dividend?

There are no upcoming dividends for Protagonist Therapeutics.

When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?

Protagonist Therapeutics does not have any upcoming earnings scheduled.

Is Protagonist Therapeutics (PTGX) going to split?

There is no upcoming split for Protagonist Therapeutics.

What sector and industry does Protagonist Therapeutics (PTGX) operate in?

Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Protagonist Therapeutics (PTGX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline p...

Comments